Castle Biosciences (CSTL) Net Margin (2018 - 2026)
Castle Biosciences (CSTL) posted Net Margin of 1.99% for Q2 2026, up 88.54% sequentially from 17.35% in Q1 2026, and down 728.0% YoY from 0.32% in Q2 2025.
Castle Biosciences (CSTL) Net Margin (2018 - 2026) Analysis & Trends
Castle Biosciences has reported Net Margin for 9 years, with the latest figure at 1.99% in Q2 2026.
- Quarterly Net Margin fell 728.0% year-over-year to 1.99% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 5.43% (down 271.0% YoY) and the FY2025 annual result came in at 7.02%, down 1251.0% from the prior year.
- Net Margin climbed to 1.99% in Q2 2026 per CSTL's latest filing, from 17.35% in the prior quarter.
- Over five years, Net Margin peaked at 11.11% in Q4 2024 and troughed at 91.7% in Q1 2022.
- A 5-year average of 19.62% and a median of 4.32% in 2022 frame the typical range for Net Margin.
- The sharpest annual moves came in 2022 and 2024: Net Margin sank 7294 bps in 2022, then soared 6600 bps in 2024.
- Over 5 years, Net Margin stood at 53.78% in 2022, then soared by 93 bps to 3.9% in 2023, then soared by 385 bps to 11.11% in 2024, then tumbled by 124 bps to 2.68% in 2025, then gained by 26 bps to 1.99% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 1.99%, 17.35%, and 2.68% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 13.89% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 27.82% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 18.47% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 5.52% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.22% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.86% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 22.67% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.65% |
| 10 | Castle Biosciences | 926.56 Mn | 659.75 Mn | 79.85 Mn | -1.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.99% |
| Mar 31, 2026 | -17.35% |
| Dec 31, 2025 | -2.68% |
| Sep 30, 2025 | -0.60% |
| Jun 30, 2025 | 5.29% |
| Mar 31, 2025 | -29.38% |
| Dec 31, 2024 | 11.11% |
| Sep 30, 2024 | 2.65% |
| Jun 30, 2024 | 10.25% |
| Mar 31, 2024 | -3.47% |
| Dec 31, 2023 | -3.90% |
| Sep 30, 2023 | -11.23% |
| Jun 30, 2023 | -37.45% |
| Mar 31, 2023 | -69.47% |
| Dec 31, 2022 | -53.78% |
| Sep 30, 2022 | -54.71% |
| Jun 30, 2022 | -4.73% |
| Mar 31, 2022 | -91.70% |
| Dec 31, 2021 | -53.44% |
| Sep 30, 2021 | -50.23% |